|

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

RECRUITINGPhase 3Sponsored by Novo Nordisk A/S
Actively Recruiting
PhasePhase 3
SponsorNovo Nordisk A/S
Started2026-08-31
Est. completion2028-06-27
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations41 sites

Summary

The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as oral tablets once a day. Participants will either get zenagamtide (the treatment being tested) or Placebo (treatment that has no active medicine in it). Which treatment participants get is decided by chance.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Male or female (sex at birth).
* Age 18 and older (both inclusive) at time of signing the informed consent.

Exclusion Criteria:

* Glycated haemoglobin (HbA1c) more than or equal to (≥) 6.5% \[48 millimoles per mole (mmol/mol)\] as measured by the central laboratory at screening.
* History of type 1 or type 2 diabetes mellitus as declared by the participant or reported in the medical records.
* Treatment with glucagon-like peptide-1 (GLP-1) receptor agonists (RA), dual GLP-1/gastric inhibitory peptide (GIP) RAs (or any other GLP-1 based treatment) or amylin analogues before screening.

Conditions3

ObesityOverweightWeight Loss

Interventions1

Locations41 sites

Pinnacle Research Group LLC
Anniston, Alabama, 36207
Univ of Alabama Birmingham
Birmingham, Alabama, 35294
Chambliss Clinical Trials LLC
Montgomery, Alabama, 36106
Providence Medical Foundation
Fullerton, California, 92835
Torrance Clinical Research Institute, Inc.
Lomita, California, 90717

Find trials near these locations

Related trials

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.